These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 19486277

  • 1. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.
    Wiegand J, Luz B, Mengelkamp AK, Moog R, Koscielny J, Halm-Heinrich I, Susemihl C, Bentzien F, Diekmann J, Wernet D, Karger R, Angert K, Schmitt-Thomssen A, Kiefel V, Lutter K, Hesse R, Kätzel R, Opitz A, Luhm J, Barz D, Leib U, Matthes G, Tillmann HL.
    J Viral Hepat; 2009 Oct; 16(10):743-8. PubMed ID: 19486277
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W, Kataaha P, Mermin J, Purdy M, Otekat G, Lackritz E, Alter MJ, Downing R.
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [Abstract] [Full Text] [Related]

  • 3. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
    Pahuja S, Sharma M, Baitha B, Jain M.
    Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
    [Abstract] [Full Text] [Related]

  • 4. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
    Shang G, Seed CR, Wang F, Nie D, Farrugia A.
    Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.
    Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK.
    Indian J Public Health; 2006 Jun; 50(1):43-4. PubMed ID: 17193761
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prevalence of HIV and HBs antigen in blood donors. Residual risk of contamination in blood recipients in East Kinshasa, Democratic Republic of the Congo].
    Mbendi Nlombi C, Longo-Mbenza B, Mbendi Nsukini S, Muyembe Tamfum JJ, Situakibanza Nanituma H, Vangu Ngoma D.
    Med Trop (Mars); 2001 Jun; 61(2):139-42. PubMed ID: 11582869
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS, Singh NB, Singh HL, Singh YM.
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.